- Exchange: London
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Summit Corp PLC+ Add to Watchlist
SUMM:LN135.0000 GBp 10.0000 8.00%
As of 11:30:00 ET on 10/24/2014.
Company Profile for Summit Corp PLC (SUMM)
Summit Corporation plc is a drug discovery and development Company targeting areas of high unmet medical need. The Company is advancing two clinical-stage programmes: Utrophin modulators for the treatment of all genetic forms of the fatal disease, Duchenne Muscular Dystrophy, and a novel antibiotic for the selective treatment of infections caused by C. difficile bacteria.
Summit Corp PLC
Key Executives for Summit Corp PLC (SUMM)
|Glyn O EdwardsChief Executive Officer||Erik OstrowskiChief Financial Officer|